Recent News
Posted January 13, 2025
"Hematologist Mary Cushman, M.D., M.Sc., University Distinguished Professor of Medicine and Pathology & Laboratory Medicine at the Larner College of Medicine and medical director of the Thrombosis and Hemostasis Program at the University of Vermont
Medical Center, spoke with Woman’s World about deep vein thrombosis (DVT). "...
Posted January 10, 2025
"ALS is a devastating neurodegenerative disease, and while there is no cure, ongoing research continues to offer hope for more effective treatments. An individual at the forefront of these efforts is Dr. Kathryn Morelli, an assistant professor in
the Department of Neurological Sciences at the University of Vermont’s Larner College of Medicine, whose research aims to address the complex challenges of ALS, building on work she did with her postdoctoral mentor Dr. Gene Yeo. Working closely
with Abby Kirch, a PhD student in her lab, Kathy and her team are focused on developing RNA-targeted therapies for ALS, particularly for the C9ORF72 mutation, one of the most common genetic causes of the disease "...
Posted January 2, 2025
"A team of UVM scientists led by University Distinguished Professor and Chair of Pharmacology Mark Nelson, Ph.D., from the Larner College of Medicine at the University of Vermont, has uncovered a novel mechanism that reshapes our understanding of
how blood flow is regulated in the brain. The study, published in Proceedings of the National Academy of Sciences (PNAS), a high-impact, peer-reviewed journal of the National Academy of Sciences (NAS), introduces electro-calcium (E-Ca) coupling,
a process that integrates electrical and calcium signaling in brain capillaries to ensure precise blood flow delivery to active neurons. "...
Posted December 4, 2024
"On November 16, Larner Assistant Professor of Medicine Debora Kamin Mukaz, Ph.D., M.S., moderated a panel on science policy advocacy titled “How can we engage scientists
from historically underrepresented backgrounds in policymaking and advocacy?” at the American Heart Association’s Scientific Sessions 2024 conference in Chicago. The panelists were AHA President Keith Churchwell, M.D.; past AHA President
Michelle Albert, M.D., M.P.H.; Emelia Benjamin, M.D., Sc.M., associate provost and professor of medicine and epidemiology at Boston University; and Carl Streed, Jr., M.D., M.P.H., associate professor of medicine at Boston University... "
Posted December 3, 2024
"Neurodegeneration in spider brain leads Vermont neuroscientists to groundbreaking discovery in Alzheimer’s-affected human brains
Vermont Business Magazine Researchers from Saint Michael’s College and the University of Vermont
have made a groundbreaking new discovery that provides a better understanding of how Alzheimer’s disease develops in the human brain..."
Posted October 23, 2024
"In a recent paper published in Nature Communications titled “Endothelial Piezo1 Channel Mediates Mechano-Feedback Control of Brain Blood Flow,” Osama Harraz, Ph.D., Bloomfield Early Career Professor in Cardiovascular Research and assistant
professor of pharmacology at the Robert Larner, M.D. College of Medicine, and his team of researchers from American and European institutions reveal that Piezo1, a lesser-understood protein, acts as a “brake” system, helping blood flow
return to normal after neural activity... "
Posted October 23, 2024
"Leptin is an adipokine associated with obesity and with hypertension in animal models. Whether leptin is associated with hypertension independent of obesity is unclear. Relative to White adults, Black adults have higher circulating leptin concentration..."
Posted October 23, 2024
"The HEALthy Brain and Child Development (HBCD) Study, a multi-site prospective longitudinal cohort study, will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early childhood...
"
Posted October 16, 2024
"Osama Harraz, Ph.D and his team of researchers at the University of Vermont’s Larner College of Medicine have made a breakthrough that could help in the effort to better understand the causes of dementia and how to stop it..."
Posted October 14, 2024
"REGARDS Study Grant Renewed:
UVM’s Continued Contributions to Research on Stroke Disparities by Race and Geography. Investigators at the Larner College of Medicine are receiving a $10.1 million multi-year grant from the National Institutes of Health (NIH) to continue
their 23-year program studying stroke and cognitive disorders in the United States... "
Posted October 2, 2024
"Investigators at the Larner College of Medicine have received a $10.1 million multi-year grant from the National Institutes of Health to continue their work on the REGARDS project. The purpose of the project is to understand why those
in some U.S. regions develop more strokes and Alzheimer’s Disease and Related Dementia than others, and why Black people develop more strokes than white people..."
Posted August 21, 2024
"Mark Nelson, Ph.D., chair and University Distinguished Professor of pharmacology, gave the Björn Folkow Lecture at the 15th Mechanisms of Vasodilation/Endothelium-Dependent Hyperpolarization (MOVD/EDH) 2024 conference July 2–5
at Magdalen College in Oxford, United Kingdom..."
Posted July 31, 2024
"A collaborative research team co-led by investigators David Jangraw, Ph.D., M.S., and Denise Peters, Ph.D., D.P.T., PT, has been awarded the 2024 Armin Grams Memorial Research Award by the Center on Aging..."
Posted July 10, 2024
"Two Larner-affiliated researchers won their respective poster competitions at the Vermont Center for Cardiovascular and Brain Health symposium held June 6–7 at the University of Vermont’s Davis
Center..."
Posted June 18, 2024
"Scientists at Larner College of Medicine exploring the intricate heart-brain connection showcased their findings at the Vermont Center for Cardiovascular and Brain Health (VCCBH) symposium at UVM’s Davis Center..."
Posted May 28, 2024
"The Cancer Population Science research program at the University of Vermont Cancer Center recently announced the winners of its pilot awards. The pilot awards are a unique philanthropy-funded mechanisms to support members conducting population-based
research..."
More News >